<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//megstage.blueprintgenetics.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/</loc>
		<lastmod>2025-05-21T08:09:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/suomalainen-yhtio-tarjoaa-kansainvalisille-markkinoille-huipputason-geeniteknologiaa/</loc>
		<lastmod>2013-06-12T11:15:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/a-finnish-company-enters-international-markets-with-world-class-genetics-technology/</loc>
		<lastmod>2013-06-12T14:03:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-accepted-into-the-tekes-niy-program/</loc>
		<lastmod>2013-12-12T11:18:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-is-launching-new-products-for-hyperlipidemia-and-nephrotic-syndrome/</loc>
		<lastmod>2014-02-14T12:20:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-launches-new-tests-for-neurological-diseases/</loc>
		<lastmod>2014-03-10T14:01:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-announces-3-9-million-funding-leading-us-expansion-2/</loc>
		<lastmod>2014-08-29T06:21:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-announces-3-9-million-in-funding-leading-to-us-expansion/</loc>
		<lastmod>2014-08-29T11:02:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-is-launching-new-products-neurological-diseases/</loc>
		<lastmod>2014-11-03T09:43:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/big-news-for-blueprint-genetics-at-the-2015-annual-clinical-genetics-meeting/</loc>
		<lastmod>2015-03-24T15:31:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/exceptional-findings-with-os-seq-in-an-arrhythmia-patient/</loc>
		<lastmod>2015-04-09T11:15:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/investigating-the-genetic-landscape-of-dcm-in-the-finnish-population/</loc>
		<lastmod>2015-08-27T06:17:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/cost-effective-and-comprehensive-genetic-profiling-of-pulmonary-arterial-hypertension-patients-with-blueprint-genetics-pah-panel/</loc>
		<lastmod>2015-09-02T08:48:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/diagnostics-startup-blueprint-genetics-puts-expansion-to-the-test-tekes/</loc>
		<lastmod>2015-11-15T19:52:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/prevalence-of-titin-truncating-variants-in-general-population/</loc>
		<lastmod>2016-01-11T13:45:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/relevance-of-truncating-titin-mutations-in-dilated-cardiomyopathy/</loc>
		<lastmod>2016-01-28T07:31:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/iso15189accreditation/</loc>
		<lastmod>2016-02-02T13:03:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/startup/</loc>
		<lastmod>2016-02-05T13:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/delivering-fast-accurate-results-patients-undergoing-genetic-testing/</loc>
		<lastmod>2016-10-05T09:38:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-kauppalehti-optio/</loc>
		<lastmod>2016-11-24T13:59:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-listed-one-hottest-start-companies-finland/</loc>
		<lastmod>2017-02-21T08:07:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/ird-patients/</loc>
		<lastmod>2017-05-03T14:05:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/newcancerpanels/</loc>
		<lastmod>2017-06-27T05:53:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/new-panels-genetic-testing-suspected-skeletal-dysplasia-skeletal-disorder/</loc>
		<lastmod>2017-06-28T06:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/intronicvariants/</loc>
		<lastmod>2017-06-30T12:00:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/updated-improved-ophthalmology-genetic-diagnostic-offering/</loc>
		<lastmod>2017-07-18T08:59:09+00:00</lastmod>
		<image:image>
			<image:loc>https://megstage.blueprintgenetics.com/wp-content/uploads/2017/06/SingleExonDeletion.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/highest-quality-genetic-testing/</loc>
		<lastmod>2017-11-01T13:34:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/new-ophthalmology-panels/</loc>
		<lastmod>2018-03-27T10:50:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/introducing-targeted-malformations-panel-content/</loc>
		<lastmod>2018-03-27T11:20:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/cardiology-case-month-path-correct-diagnosis/</loc>
		<lastmod>2018-03-27T11:21:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/phenotype-diagnosis-blueprint-genetics-launches-open-digital-platform-connect-clinicians-based-matching-rare-variants/</loc>
		<lastmod>2018-04-12T15:13:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/difficult-sequence-genes-ophthalmology-improved-sequencing-coverage-mapping-quality-orf15-enable-unmatched-diagnostic-yield-xlrp/</loc>
		<lastmod>2018-04-30T11:14:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/setting-new-standard-quality-cardiology/</loc>
		<lastmod>2018-05-02T16:27:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/new-immunology-primary-immunodeficiency-primary-ciliary-dyskinesia-panel/</loc>
		<lastmod>2018-06-12T08:28:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/a-finnish-study-finds-evidence-indicating-the-jph2-gene-to-be-causative-in-hypertrophic-cardiomyopathy/</loc>
		<lastmod>2018-09-21T09:21:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-strengthens-its-pharmaceutical-expertise-with-new-chairman/</loc>
		<lastmod>2018-12-05T08:26:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-valittu-vuoden-2017-kasvunrakentajaksi/</loc>
		<lastmod>2019-02-12T11:57:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/quest-diagnostics-acquires-blueprint-genetics-to-broaden-access-to-actionable-insights-for-genetic-and-rare-diseases/</loc>
		<lastmod>2020-01-22T11:02:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/nicer-and-blueprint-genetics-collaborate-to-improve-genetic-testing-for-immunologic-and-hematologic-disorders/</loc>
		<lastmod>2020-04-20T14:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/our-commitment-to-providing-you-with-high-quality-service-during-covid-19/</loc>
		<lastmod>2020-06-17T09:18:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/high-quality-panel-based-testing-with-mitochondrial-dna-analysis/</loc>
		<lastmod>2020-06-17T09:28:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/proqr-therapeutics-teams-up-with-the-foundation-fighting-blindness-and-blueprint-genetics-to-support-the-my-retina-tracker-program-for-people-living-with-inherited-retinal-diseases/</loc>
		<lastmod>2020-06-17T12:07:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-updates-panels-and-prepares-to-launch-mitochondrial-dna-testing/</loc>
		<lastmod>2020-06-17T12:32:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/open-access-program-for-patients-with-inherited-retinal-disease-united-states/</loc>
		<lastmod>2020-06-18T07:12:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-archimedlife-partnership-biochemical-testing-rare-diseases-north-america/</loc>
		<lastmod>2020-06-18T07:41:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/move-announcement-new-facility-in-seattle-what-you-need-to-know/</loc>
		<lastmod>2020-06-18T07:50:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/new-address-announcement-blueprint-genetics-establishes-a-new-laboratory-in-finland/</loc>
		<lastmod>2020-06-18T07:59:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/building-new-clia-cap-ngs-facility-seattle/</loc>
		<lastmod>2020-06-18T08:26:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/study-183-index-patients-enhanced-diagnostic-performance-ngs-panels-pkd1/</loc>
		<lastmod>2020-06-18T08:40:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/latest-panel-update-introducing-six-improved-cardiology-panels/</loc>
		<lastmod>2020-06-18T10:32:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/diagnostic-testing-for-national-eye-institute-eyegene-initiative/</loc>
		<lastmod>2020-06-18T10:50:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/introducing-new-standard-quality-updated-panels-significantly-improve-sequencing-depth-sensitivity/</loc>
		<lastmod>2020-06-22T08:49:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/genetic-causes-of-dilated-cardiomyopathy-ttn-missense-nfs-indel-variants/</loc>
		<lastmod>2020-07-06T12:43:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-receives-biofinland-award-2017/</loc>
		<lastmod>2020-07-07T12:36:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/meet-sampo-nextseq-500-desktop-sequencer/</loc>
		<lastmod>2020-07-08T11:30:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/new-and-improved-clinical-report/</loc>
		<lastmod>2020-09-02T08:17:02+00:00</lastmod>
		<image:image>
			<image:loc>https://megstage.blueprintgenetics.com/wp-content/uploads/2020/09/samplereportimage.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/agtc-joins-the-my-retina-tracker-program-as-a-new-scientific-collaborator/</loc>
		<lastmod>2020-10-07T11:01:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/panel_based_approach_to_clinical_genetics/</loc>
		<lastmod>2020-10-13T10:21:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/deletions-duplications/</loc>
		<lastmod>2020-10-13T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/new-service-connections-clinicians-based-identically-matching-variants/</loc>
		<lastmod>2020-10-13T10:28:05+00:00</lastmod>
		<image:image>
			<image:loc>https://megstage.blueprintgenetics.com/wp-content/uploads/2017/01/BlueprintGenetics_nucleus_-e1488357215221.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/high-diagnostic-accuracy-provided-by-blueprint-genetics-technologies-is-essential-for-clinical-diagnostics/</loc>
		<lastmod>2020-10-23T12:38:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/a-clear-path-to-early-treatment-through-cost-effective-actionable-genetic-diagnostics/</loc>
		<lastmod>2020-10-23T12:49:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/new-buccal-swabs-for-easier-sample-collection-available/</loc>
		<lastmod>2020-11-23T12:43:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/akouos-and-blueprint-genetics-announce-the-resonate-program/</loc>
		<lastmod>2021-01-11T12:32:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/study-nrap-gene-significant-cause-of-recessive-dilated-cardiomyopathy/</loc>
		<lastmod>2021-02-03T19:02:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/acmg2021_quest-diagnostics-and-blueprint-genetics-to-present-new-insights-from-genetic-testing/</loc>
		<lastmod>2021-04-13T12:10:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/the-my-retina-tracker-genetic-testing-program-continues-to-expand/</loc>
		<lastmod>2021-05-25T14:10:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/research-collaboration-aims-to-accelerate-rare-disease-diagnostics/</loc>
		<lastmod>2021-09-09T10:01:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/enhanced-access-to-genetic-testing-for-individuals-with-auditory-neuropathy-the-resonate-program-by-akouos-offers-healthcare-providers-online-ordering-of-genetic-testing-through-blueprint-genetics/</loc>
		<lastmod>2021-09-22T14:01:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/new-study-in-pediatric-epilepsy/</loc>
		<lastmod>2021-10-05T08:17:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-and-biomarin-collaborate-to-launch-discover-dysplasias-program/</loc>
		<lastmod>2021-10-26T11:18:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-further-enhances-the-clinical-utility-of-its-testing-offering-with-a-major-panel-update/</loc>
		<lastmod>2021-11-25T11:27:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/new-research-collaboration-helps-shorten-the-path-to-diagnosis-for-rare-disease-patients-through-analysis-of-biobank-samples/</loc>
		<lastmod>2022-06-07T07:51:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/our-service-hours-during-the-holiday-season-2/</loc>
		<lastmod>2023-06-21T09:58:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/high-quality-reproductive-screening-duo-tests-added-to-blueprint-genetics-product-portfolio/</loc>
		<lastmod>2023-11-16T12:23:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/our-service-hours-during-the-holiday-season-3/</loc>
		<lastmod>2023-12-22T17:08:08+00:00</lastmod>
		<image:image>
			<image:loc>https://megstage.blueprintgenetics.com/wp-content/uploads/2023/12/1657f9d6-1cd5-486d-9703-e2770859a02c_IPWarming_Image.jpeg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-introduces-the-new-screening-tests-family-giving-actionable-insights-for-family-planning-and-future-health/</loc>
		<lastmod>2024-02-16T11:14:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-introduces-6-new-reproductive-carrier-screening-tests-with-fmr1-repeat-expansion/</loc>
		<lastmod>2024-10-08T09:52:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/diagnostic-tests-with-fmr1-repeat-expansion-added-to-blueprint-genetics-offering/</loc>
		<lastmod>2024-10-28T11:08:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-a-quality-leader-in-genetic-testing-embraces-new-eu-regulation-ivdr/</loc>
		<lastmod>2024-11-07T11:34:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/our-service-hours-during-the-holidays-2024-2025/</loc>
		<lastmod>2024-12-17T10:35:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/blueprint-genetics-expands-capabilities-in-the-detection-and-confirmation-of-difficult-to-sequence-regions/</loc>
		<lastmod>2025-02-13T12:56:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://megstage.blueprintgenetics.com/news/sequencing-services-for-whole-genome-and-whole-exome-research-use/</loc>
		<lastmod>2025-05-21T08:09:09+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->